|
|
|
|
|
11.03.26 - 08:03
|
FR Regulatory News: ROCTOOL (EQS)
|
|
|
ROCTOOL: Compose Manufacturing Expands Roctool-Enabled production capacity in Asia with ten new induction systems...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
09.03.26 - 18:57
|
Precision Aviation Services, a subsidiary of Precision Aviation Group, Named Authorized Autopilot Installer for Thales and StandardAero StableLight™ System Ahead of Verticon 2026 (PR Newswire)
|
|
|
ATLANTA, March 9, 2026 /PRNewswire/ -- Precision Aviation Services, a subsidiary of Precision Aviation Group, Inc. (PAG), a leading provider of maintenance, repair, and overhaul (MRO) and value-added services for the aerospace and defense industries, today announced it has been approved......
|
|
|
09.03.26 - 18:01
|
MaaT Pharma to Present Four Abstracts at the 52nd European Bone Marrow Transplantation Annual Meeting and to Highlight Clinigen-Hosted Industry Symposium on acute GvHD Management (Business Wire)
|
|
|
Oral presentation during Presidential Plenary Session to feature the final results of the ARES pivotal Phase 3 trial evaluating MaaT013 in acute Graft‑versus‑Host Disease (aGvHD) with gastrointestinal involvement
Poster presentations for:
CHRONOS, a multicenter retrospective cohort study describing real-world outcomes in third-line acute gastrointestinal GvHD not treated with microbiotherapy
PHOEBUS, a Phase 2b trial, potentially pivotal, evaluating MaaT033 seeking to improve survival after allogeneic hematopoietic transplantation (HCT)
THRASSA, a multicenter, open‑label paediatric/adolescent study evaluating MaaT013 in patients with ruxolitinib‑refractory or ruxolitinib‑intolerant gastrointestinal aGvHD
Clinigen, MaaT Pharma's strategic commercial partner for MaaT013's Early Access Program and commercialization in Europe pending European Medicines Agency (EMA) approval, will host an Industry Symposium on advancing care for steroid-refractory gastrointestinal aGvHD
LYON, France--(BUSINESS WIRE...
|
|
|
09.03.26 - 17:48
|
Séché Environnement: 2025 Consolidated Results (Business Wire)
|
|
|
Results impacted by the decline in certain circular economy activities in France despite solid growth internationally
Strong free cash flow generation
Improved financial flexibility
OUTLOOK FOR 2026
Improvement in operating margins and deleveraging
CONTRIBUTED REVENUE: €1,152m, up 3.7% vs. 2024
EBITDA: €225m, down 7.0% vs. 2024
Net income (Group share): €21m, down 39% vs. 2024
Net financial debt (IFRS): €549m, down 35.4% vs. 2024
IFRS financial leverage: 2.3x EBITDA, down 0.9 pt vs. 2024
PROPOSED DIVIDEND1: €1.20 PER SHARE (unchanged)
PURSUIT OF A TARGETED EXTERNAL GROWTH STRATEGY
Planned acquisition of Groupe Flamme in France
Acquisition of La Filippa in Italy
Acquisition of Hidronor, Chile's leading hazardous waste management company
2026 TARGETS: PRIORITY ASSIGNED TO INCREASING OPERATING PROFITABILITY AND DELEVERAGING
Contributed revenue: up by around 2-3% across the historical scope + contribution from acquisitions made at the beginning of the financial year, targeting total contributed r...
|
|
|
|
|
|
|
09.03.26 - 12:21
|
SAFRAN Outperform (DPA-AFX)
|
|
|
NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat Safran auf "Outperform" belassen. Falls der Iran-Krieg und die daraus resultierenden Einschränkungen im Flugverkehr nicht lange dauerten, seien nur begrenzte Risiken für die Flugzeugbauer ......
|
|
|
|
|
|
|
|
|
06.03.26 - 12:15
|
SAFRAN Outperform (DPA-AFX)
|
|
|
NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat das Kursziel für Safran von 400 auf 410 Euro angehoben und die Einstufung auf "Outperform" belassen. Von einer dreitägigen Schulungsveranstaltung für junge Analysten brachte Analyst ......
|
|
|
06.03.26 - 11:06
|
SAFRAN Buy (DPA-AFX)
|
|
|
NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat das Kursziel für Safran von 340 auf 360 Euro angehoben und die Einstufung auf "Buy" belassen. Analyst Sam Burgess passte seine Schätzungen am Freitag an die Jahresbilanz der Franzosen ......
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
